BIM
JAZZ icon

Bridges Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bridges Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,465
Closed -$252K – 270
2018
Q2 		$252K Hold
1,465
– – 0.01% 239
2018
Q1 		$221K Buy
+1,465
New +$215K 0.01% 241
2017
Q4 		– Sell
-1,425
Closed -$209K – 197
2017
Q3 		$209K Buy
+1,425
New +$216K 0.02% 147
2017
Q2 		– Sell
-1,435
Closed -$208K – 131
2017
Q1 		$208K Buy
+1,435
New +$187K 0.03% 122

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridges Investment Management's JAZZ Position: Q3 2018 in Review

Bridges Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2018, closing a stake of 1,465 shares — an estimated $252K sold.

Bridges Investment Management first reported a position in JAZZ in Q1 2017 and held it in 4 quarters. The position peaked at $252K in Q2 2018. 403 funds tracked by Wall St. Rank hold JAZZ as of Q3 2018.

  • Bridges Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Bridges Investment Management sold 1,465 Jazz Pharmaceuticals shares in Q3 2018, an estimated $252K.
  • Bridges Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 4 quarters.
  • Bridges Investment Management's Jazz Pharmaceuticals position peaked at $252K in Q2 2018.
  • 403 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2018.

Based on Bridges Investment Management's 13F filing for Q3 2018, filed 15 Nov 2018.